APA (7th ed.) Citation

A, S., R, P., J, D., R, A., A, K., J, B., . . . W, S. (2023). Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results. Cell reports. Medicine, 4(2), 100916. https://doi.org/10.1016/j.xcrm.2023.100916

Chicago Style (17th ed.) Citation

A, Saeed, et al. "Cabozantinib Plus Durvalumab in Advanced Gastroesophageal Cancer and Other Gastrointestinal Malignancies: Phase Ib CAMILLA Trial Results." Cell Reports. Medicine 4, no. 2 (2023): 100916. https://doi.org/10.1016/j.xcrm.2023.100916.

MLA (9th ed.) Citation

A, Saeed, et al. "Cabozantinib Plus Durvalumab in Advanced Gastroesophageal Cancer and Other Gastrointestinal Malignancies: Phase Ib CAMILLA Trial Results." Cell Reports. Medicine, vol. 4, no. 2, 2023, p. 100916, https://doi.org/10.1016/j.xcrm.2023.100916.